1. Home
  2. AMWL vs CRBP Comparison

AMWL vs CRBP Comparison

Compare AMWL & CRBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMWL
  • CRBP
  • Stock Information
  • Founded
  • AMWL 2006
  • CRBP 2009
  • Country
  • AMWL United States
  • CRBP United States
  • Employees
  • AMWL N/A
  • CRBP N/A
  • Industry
  • AMWL Retail: Computer Software & Peripheral Equipment
  • CRBP Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMWL Technology
  • CRBP Health Care
  • Exchange
  • AMWL Nasdaq
  • CRBP Nasdaq
  • Market Cap
  • AMWL 106.7M
  • CRBP 110.3M
  • IPO Year
  • AMWL 2020
  • CRBP N/A
  • Fundamental
  • Price
  • AMWL $7.01
  • CRBP $9.31
  • Analyst Decision
  • AMWL Hold
  • CRBP Strong Buy
  • Analyst Count
  • AMWL 7
  • CRBP 10
  • Target Price
  • AMWL $9.67
  • CRBP $53.56
  • AVG Volume (30 Days)
  • AMWL 60.5K
  • CRBP 128.8K
  • Earning Date
  • AMWL 08-05-2025
  • CRBP 08-12-2025
  • Dividend Yield
  • AMWL N/A
  • CRBP N/A
  • EPS Growth
  • AMWL N/A
  • CRBP N/A
  • EPS
  • AMWL N/A
  • CRBP N/A
  • Revenue
  • AMWL $261,675,000.00
  • CRBP N/A
  • Revenue This Year
  • AMWL $2.70
  • CRBP N/A
  • Revenue Next Year
  • AMWL $7.06
  • CRBP $270.04
  • P/E Ratio
  • AMWL N/A
  • CRBP N/A
  • Revenue Growth
  • AMWL 2.79
  • CRBP N/A
  • 52 Week Low
  • AMWL $6.10
  • CRBP $4.64
  • 52 Week High
  • AMWL $12.95
  • CRBP $61.89
  • Technical
  • Relative Strength Index (RSI)
  • AMWL 36.22
  • CRBP 62.56
  • Support Level
  • AMWL $7.93
  • CRBP $9.00
  • Resistance Level
  • AMWL $9.05
  • CRBP $10.06
  • Average True Range (ATR)
  • AMWL 0.54
  • CRBP 0.58
  • MACD
  • AMWL -0.18
  • CRBP 0.07
  • Stochastic Oscillator
  • AMWL 6.21
  • CRBP 63.21

About AMWL American Well Corporation

American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others.

About CRBP Corbus Pharmaceuticals Holdings Inc.

Corbus Pharmaceuticals Holdings Inc is a precision oncology company with a diversified portfolio and is committed to helping people defeat serious illness by bringing scientific approaches to well-understood biological pathways. The company's development pipeline includes; CRB-701, a next-generation antibody-drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload, CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGF expressed on cancer cells, and CRB-913 a second-generation peripherally restricted CB1 receptor inverse agonist designed to treat obesity.

Share on Social Networks: